Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3/A Insider 3/A
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 10,000 shares (grant or award)
  7. 4 Grant or award Director acquired 10,000 shares (grant or award)
  8. 4 Grant or award Director acquired 10,000 shares (grant or award)
  9. 4 Grant or award Director acquired 10,000 shares (grant or award)
  10. 4 Grant or award Director acquired 10,000 shares (grant or award)
  11. 4 Grant or award SVP, Fin+Admin, CFO & Treas acquired 55,000 shares (grant or award)
  12. 4 Grant or award SVP, GC and Secretary acquired 45,000 shares (grant or award)
  13. 4 Grant or award President & CEO acquired 175,000 shares (grant or award)
  14. 4 Grant or award VP, Clin Pharm Sciences acquired 45,000 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 37 · 739 filings